Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 14 December 2022 31 December 2023 31 December 2023 14540638 Dr M Mitchison iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14540638 2022-12-13 14540638 2023-12-31 14540638 2022-12-14 2023-12-31 14540638 frs-core:CurrentFinancialInstruments 2023-12-31 14540638 frs-bus:PrivateLimitedCompanyLtd 2022-12-14 2023-12-31 14540638 frs-bus:FilletedAccounts 2022-12-14 2023-12-31 14540638 frs-bus:Micro-entities 2022-12-14 2023-12-31 14540638 frs-bus:AuditExempt-NoAccountantsReport 2022-12-14 2023-12-31 14540638 frs-bus:Director1 2022-12-14 2023-12-31
Registered number: 14540638
Pathology Direct Ltd
Unaudited Financial Statements
For the Period 14 December 2022 to 31 December 2023
Ballards Newman
Chartered Accountants
Apex House
Grand Arcade
North Finchley
London
N12 0EH
Balance Sheet
Registered number: 14540638
31 December 2023
£
Fixed assets 2,640
Current assets 77,337
Creditors: Amounts Falling Due Within One Year (19,428 )
NET CURRENT ASSETS 57,909
TOTAL ASSETS LESS CURRENT LIABILITIES 60,549
Accruals and deferred income (1,920 )
NET ASSETS 58,629
CAPITAL AND RESERVES 58,629

Notes

1. General Information
Pathology Direct Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14540638 . The registered office is 71-75 Shelton Street, Covent Garden, London, United Kingdom, WC2H 9JQ.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr M Mitchison
Director
7 August 2024